Last updated: April 19, 2026

Examiner: VIVLEMORE, TRACY ANN

Tech Center 4100 • Art Units: 1600 1635 1638 1674 4100 4151

This examiner grants 74% of resolved cases

Performance Statistics

73.5%

Allow Rate

+13.5% vs TC avg

723

Total Applications

+5.4%

Interview Lift

1051

Avg Prosecution Days

Based on 713 resolved cases, 2023–2026

2.8%

§101 Eligibility

22.4%

§102 Novelty

31.5%

§103 Obviousness

21.5%

§112 Clarity

App #	Title	Status	Assignee
17294074	THERAPEUTIC ADENO-ASSOCIATED VIRUS FOR TREATING POMPE DISEASE	Final Rejection	ASKBIO INC.
18301240	TWO-PLASMID SYSTEM FOR PRIME EDITING IN YEAST, USE THEREOF, AND METHOD FOR PRIME EDITING IN YEAST	Non-Final OA	ZJU-HANGZHOU GLOBAL SCIENTIFIC AND TECHNOLOGICAL INNOVATION CENTER
18255690	INTERFERING RNAS TARGETING SEVERE ACUTE RESPIRATORY SYNDROME-ASSOCIATED CORONAVIRUS AND USES THEREOF FOR TREATING COVID-19	Non-Final OA	ONENESS BIOTECH CO. LTD.

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.